1,495
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Adipocytes are larger in lymphedematous extremities than in controls

, & ORCID Icon
Pages 172-179 | Received 02 Feb 2021, Accepted 01 Jul 2021, Published online: 02 Aug 2021

References

  • Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92(6):1368–1377.
  • Rockson SG. Lymphedema. Curr Treat Options Cardiovasc Med. 2006;8(2):129–136.
  • Cabral S, Bonfim C, Oliveira R, et al. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration. Rev Inst Med Trop Sao Paulo. 2017;59:e23.
  • Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg. 2010;126(3):752–758.
  • Piller NB, Thelander A. Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31(2):74–86.
  • Brorson H, Ohlin K, Olsson G, et al. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol. 2006;4(4):199–210.
  • Hoffner M, Bagheri S, Hansson E, et al. SF-36 shows increased quality of life following complete reduction of postmastectomy lymphedema with liposuction. Lymphat Res Biol. 2017;15(1):87–98.
  • Brorson H. Liposuction in lymphedema treatment. J Reconstr Microsurg. 2016;32(1):56–65.
  • Brorson H, Ohlin K, Olsson G, et al. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol. 2009;7(1):3–10.
  • Zampell JC, Aschen S, Weitman ES, et al. Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg. 2012;129(4):825–834.
  • Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg. 2014;134(1):154e–160e.
  • Harvey NL, Srinivasan RS, Dillard ME, et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet. 2005;37(10):1072–1081.
  • Schneider M, Conway EM, Carmeliet P. Lymph makes you fat. Nat Genet. 2005;37(10):1023–1024.
  • Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids. 2005;73(1):17–30.
  • Borley NR, Mortensen NJ, Jewell DP, et al. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol. 2000;190(2):196–202.
  • Sadler D, Mattacks CA, Pond CM. Changes in adipocytes and dendritic cells in lymph node containing adipose depots during and after many weeks of mild inflammation. J Anat. 2005;207(6):769–781.
  • Rockson SG. The elusive adipose connection. Lymphat Res Biol. 2004;2(3):105–106.
  • Aschen S, Zampell JC, Elhadad S, et al. Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg. 2012;129(4):838–847.
  • Idy-Peretti I, Bittoun J, Alliot FA, et al. Lymphedematous skin and subcutis: in vivo high resolution magnetic resonance imaging evaluation. J Invest Dermatol. 1998;110(5):782–787.
  • Tashiro K, Feng J, Wu SH, et al. Pathological changes of adipose tissue in secondary lymphoedema. Br J Dermatol. 2017;177(1):158–167.
  • Tassenoy A, Vermeiren K, van der Veen P, et al. Demonstration of tissue alterations by ultrasonography, magnetic resonance imaging and spectroscopy, and histology in breast cancer patients without lymphedema after axillary node dissection. Lymphology. 2006;39(3):118–126.
  • Bjorntorp P. Size, number and function of adipose tissue cells in human obesity. Horm Metab Res. 1974;1974(Suppl. 4):77–83.
  • Smith J, Al-Amri M, Dorairaj P, et al. The adipocyte life cycle hypothesis. Clin Sci. 2006;110(1):1–9.
  • Vondrichova T, de Capretz A, Parikh H, et al. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy. Thyroid. 2007;17(6):511–517.
  • Smith TJ, Kahaly GJ, Ezra DG, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med. 2017;376(18):1748–1761.